Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,081.41. The company's market cap stands at 1.04T, with a P/E ratio of 52.60 and a dividend yield of 56.4%.
On 2026-01-12, Eli Lilly(LLY) stock moved within a range of $1,058.00 to $1,083.12. With shares now at $1,081.41, the stock is trading +2.2% above its intraday low and -0.2% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 1.7M, versus its average volume of 2.52M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Technology BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio Licensing BioAge Labs (BIOA) shares catapulted Monday on promising results for th...
Technology Nvidia Partners With Biotech Firms On AI Drug Discovery Licensing Nvidia (NVDA) on Monday announced AI partnerships with two biotech firms to transfo...
Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future Quick Read Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years...
Analyst ratings
79%
of 29 ratingsMore LLY News
10:51 EST Eli Lilly (LLY) CFO says Zepbound multi-dose pen to be approved in ‘next few months’ Claim 70% Off TipRanks Premium Published first on TheFly – the...
Eli Lilly (LLY) CFO Lucas Montarce continues being interviewed on Bloomberg Television. Published first on TheFly – the ultimate source for real-time, market-m...
U.S. pharmaceutical giant Eli Lilly (LLY) is partnering with chipmaker Nvidia (NVDA) on a new artificial intelligence (AI) research lab to be based in San Franc...
NVIDIA (NVDA) and Eli Lilly and Company (LLY) announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring chal...
Healthcare This French Biotech Stock Surged 1700% in 2025. Eli Lilly Is Taking an Interest. In this article LLY ABVX FRES Eli Lilly’s presence in France include...
Abivax rises amid report Eli Lilly is preparing a €15 billion bid French biotech Abivax rose more than 20% in premarket trading after French outlet La Lettre r...
Abivax (ABVX) ADRs rose 23% in premarket trading after a report that Eli Lilly (LLY) is preparing to offer €15 billion for the French biotech firm. Lilly (LLY)...
